These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 913565)

  • 1. Inhibitors of thromboxane synthase in human platelets.
    Alusy UD; Hammarström S
    FEBS Lett; 1977 Oct; 82(1):107-10. PubMed ID: 913565
    [No Abstract]   [Full Text] [Related]  

  • 2. Biosynthesis and biological properties of prostaglandin endoperoxides and thromboxane A2.
    Svensson J
    Acta Biol Med Ger; 1978; 37(5-6):731-40. PubMed ID: 742285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A selective thromboxane synthetase inhibitor blocks the cAMP lowering activity of PGH2.
    Gorman RR; Fitzpatrick FA; Miller OV
    Biochem Biophys Res Commun; 1977 Nov; 79(1):305-13. PubMed ID: 200243
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of platelet aggregation by 1-alkylimidazole derivatives, thromboxane A synthetase inhibitors.
    Kayama N; Sakaguchi K; Kaneko S; Kubota T; Fukuzawa T; Kawamura S; Yoshimoto T; Yamamoto S
    Prostaglandins; 1981 Apr; 21(4):543-54. PubMed ID: 7196056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human platelet thromboxane synthetase by 9,11-azoprosta-5,13-dienoic acid.
    Gorman RR; Bundy GL; Peterson DC; Sun FF; Miller OV; Fitzpatrick FA
    Proc Natl Acad Sci U S A; 1977 Sep; 74(9):4007-11. PubMed ID: 269449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of prostaglandin endoperoxides to C17-hydroxy acids catalyzed by human platelet thromboxane synthase.
    Diczfalusy U; Falardeau P; Hammarström S
    FEBS Lett; 1977 Dec; 84(2):271-4. PubMed ID: 598509
    [No Abstract]   [Full Text] [Related]  

  • 7. Modulation of human platelet function by prostacyclin and thromboxane A2.
    Gorman RR
    Fed Proc; 1979 Jan; 38(1):83-8. PubMed ID: 215465
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostaglandin H2 in human platelet activation: coactivator and substitute for thromboxane A2.
    Hornberger WB; Patscheke H
    Prog Clin Biol Res; 1989; 301():315-9. PubMed ID: 2798452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat.
    Quilley J; McGiff JC; Nasjletti A
    Br J Pharmacol; 1989 Jan; 96(1):111-6. PubMed ID: 2522332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Suppression of platelet aggregation as a result of two-component inhibition of a polyenzyme system of thromboxane synthesis].
    Varfolomeev SD; Lakin KM; Mevkh AT; Novikova NV; Rukazenkov IuZ
    Dokl Akad Nauk SSSR; 1985; 282(1):194-6. PubMed ID: 3928305
    [No Abstract]   [Full Text] [Related]  

  • 11. On the inhibitory potency of imidazole and its derivatives on thromboxane synthetase.
    Tai HH; Yuan B
    Biochem Biophys Res Commun; 1978 Jan; 80(1):236-42. PubMed ID: 623654
    [No Abstract]   [Full Text] [Related]  

  • 12. Kinetic studies on the conversion of prostaglandin endoperoxide PGH2 by thromboxane synthase.
    Anderson MW; Crutchley DJ; Tainer BE; Eling TE
    Prostaglandins; 1978 Oct; 16(4):563-70. PubMed ID: 725086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A structural requirement for the conversion of prostaglandin endoperoxides to thromboxanes.
    Diczfalusy U; Hammarström S
    FEBS Lett; 1979 Sep; 105(2):291-5. PubMed ID: 488357
    [No Abstract]   [Full Text] [Related]  

  • 14. Resolution of prostaglandin endoperoxide synthase and thromboxane synthase of human platelets.
    Hammarström S; Falardeau P
    Proc Natl Acad Sci U S A; 1977 Sep; 74(9):3691-5. PubMed ID: 410024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosynthesis of thromboxanes.
    Hammarström S; Diczfalusy U
    Adv Prostaglandin Thromboxane Res; 1980; 6():267-74. PubMed ID: 6770598
    [No Abstract]   [Full Text] [Related]  

  • 16. [Kinetic mechanisms of enzyme activity of the thromboxane synthetase system. Thromboxane synthetase of human platelets].
    Basevich VV; Mevkh AT; Varfolomeev SD
    Biokhimiia; 1984 Sep; 49(9):1538-45. PubMed ID: 6440597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biology and biochemistry of thromboxane synthetase inhibitors.
    Gorman RR
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():235-40. PubMed ID: 6221529
    [No Abstract]   [Full Text] [Related]  

  • 18. Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.
    Gorman RR
    Adv Prostaglandin Thromboxane Res; 1980; 6():417-25. PubMed ID: 6247892
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intermediary endoperoxides, lipid autacoids with a biological role].
    Nechifor M
    Rev Med Chir Soc Med Nat Iasi; 1980; 84(3):486, 562. PubMed ID: 6113630
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
    Vezza R; Mezzasoma AM; Venditti G; Gresele P
    Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.